# Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

> **NCT06044389** · — · UNKNOWN · sponsor: **Sciotec Diagnostic Technologies GmbH** · enrollment: 60 (estimated)

## Conditions studied

- Fructose Intolerance

## Interventions

- **DEVICE:** Fructosin

## Key facts

- **NCT ID:** NCT06044389
- **Lead sponsor:** Sciotec Diagnostic Technologies GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2024-06
- **Final completion:** 2024-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06044389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06044389, "Observational Study on the Safety and Efficacy of the Medical Product Fructosin.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06044389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*